Precision livestock farming (PLF) is a digital management system that continuously measures the production, reproduction, health and welfare of animals and environmental impacts of the herd by using information and communication technologies (ICT) and controls all stages of the production process. In conventional livestock management, decisions are mostly based on the appraisal, judgment, and experience of the farmer, veterinarian, and workers. The increasing demand for production and the number of animals makes it difficult for humans to keep track of animals. It is clear that a person is not able to continuously watch the animals 24 hours a day to receive reliable audio-visual data for management. Recent technologies already changed the information flow from animal to human, which helps people to collect reliable information and transform it into an operational decision-making process (eg reproduction management or calving surveillance). Today, livestock farming must combine requirements for a transparent food supply chain, animal welfare, health, and ethics as a traceable-sustainable model by obtaining and processing reliable data using novel technologies. This review provides preliminary information on the advances in ICT for livestock management.

Context: Eryngium maritimum L. and the endemic Eryngium kotschyi Boiss. of the Apiaceae family are used for antiinflammatory, antivenom, antinociceptive and diuretic purposes in folk medicine in Turkey. Objective: This study investigated the cytotoxic effects of the plant extracts belonging to Eryngium L. genus on various cell lines. Materials and methods: Cytotoxic activites of the lyophilized aqueous aereal and root parts of the plant extracts on human hepatocellular carcinoma (HepG2), human laryngeal epidermoid carcinoma (Hep2), human glioma (U138-MG) and African green monkey kidney epithelial (Vero) cell lines at 8.33–266.62 µg/ml concentrations were analyzed by lactate dehydrogenase (LDH) leakage and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) cell viability assays. Results: Inhibitory concentration 50 (IC₅₀) values were found <100 µg/ml in most cases varying around 16.33–125.66 µg/ml. IC₅₀ values for E. kostchyi and E. maritimum root parts on Hep2 cells (32.86 and 30.25 µg/ml, respectively), E. kotschyi aereal, E. maritimum aereal and root parts on HepG2 cells (31.75, 32.42 and 35.01 µg/ml, respectively) by MTT assay were found to be close to the US National Cancer Institute (NCI) recommendations (IC₅₀ < 30 µg/ml) to define the antivity aganist cancer cells. The lowest IC₅₀ values according to the LDH method were observed in Hep2 cells and the highest in U138-MG cells. Root parts were found to be more toxic than aereal parts for both plants in both methods in general. Discussion and conclusion: Both plant extracts exerted cytotoxic activity aganist Hep2 and HepG2 cells, with low IC₅₀ values defining their promising anticancer property according to NCI; however, further analysis are needed to confirm their activity.

Cytochrome P4502C9 (CYP2C9) is an important drug-metabolizing enzyme responsible for the metabolism of approximately 16% of all clinically relevant drugs. It was shown previously that the activity of CYP2C9 in vivo is inhibited by oral contraceptives. The mechanisms of this effect have not been elucidated. We hypothesize that this may occur because of the sex steroid-dependent activation of estrogen receptor α (ERα) with further transactivation of the CYP2C9 gene. Here, we show that the CYP2C9 promoter indeed contains a functionally relevant estrogen responsive element (ERE) half-site at position −149/−145. Its ERα binding activity was tested by the luciferase gene reporter assay. Promoter constructs bearing this site were cotransfected with ERα into Huh7 hepatoma cells and treated with various ERα ligands including 4-hydroxytamoxifen (4-OHT), raloxifene (R), 17β-estradiol (EE), and 17α-ethinylestradiol (ETE). The luciferase activity driven by the wild-type CYP2C9 promoter construct was up-regulated by 4-OHT and R and significantly or marginally suppressed by ETE and EE, respectively. An identical effect was observed in primary hepatocytes treated with these compounds. Mutations introduced into the ERE half-site abolished the observed effects in the Huh7 cells. Electrophoretic mobility-shift assay revealed sequence-specific binding of a nuclear protein to the oligonucleotide containing the ERE half-site, which was identified as ERα by antibody supershift analysis. In addition, the association of ERα with CYP2C9 promoter was strongly supported by chromatin immunoprecipitation data. Taken together, these results indicate that ERα and its ligands play an important role in the regulation of CYP2C9 expression.